{
    "id": 25256,
    "fullName": "EZH2 Y111N",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "EZH2 Y111N lies within the D1 domain of the Ezh2 protein (PMID: 26360609). Y111N has been demonstrated to occur as a secondary mutation that confers resistance to Ezh2 inhibitors (PMID: 26360609), but has not been biochemically characterized and therefore, its effect on Ezh2 protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 6504,
                    "pubMedId": 26360609,
                    "title": "Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26360609"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2146,
        "geneSymbol": "EZH2",
        "terms": [
            "EZH2",
            "ENX-1",
            "ENX1",
            "EZH2b",
            "KMT6",
            "KMT6A",
            "WVS",
            "WVS2"
        ]
    },
    "variant": "Y111N",
    "createDate": "08/18/2016",
    "updateDate": "10/09/2019",
    "referenceTranscriptCoordinates": {
        "id": 171518,
        "transcript": "NM_001203247",
        "gDna": "chr7:g.148832666A>T",
        "cDna": "c.331T>A",
        "protein": "p.Y111N",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 11149,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, diffuse large B-cell lymphoma cells co-expressing EZH2 F120L and EZH2 Y111N were sensitive to EED226, demonstrating inhibition of cell proliferation in culture (PMID: 28135235).",
            "molecularProfile": {
                "id": 27920,
                "profileName": "EZH2 Y111N EZH2 F120L"
            },
            "therapy": {
                "id": 5886,
                "therapyName": "EED226",
                "synonyms": null
            },
            "indication": {
                "id": 50745,
                "name": "diffuse large B-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9115,
                    "pubMedId": 28135235,
                    "title": "An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28135235"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11148,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a cancer cell line co-expressing EZH2 F120L and EZH2 Y111N was resistant to Tazemetostat (EPZ-6438) in culture, demonstrating no inhibition of cell proliferation (PMID: 28135235).",
            "molecularProfile": {
                "id": 27920,
                "profileName": "EZH2 Y111N EZH2 F120L"
            },
            "therapy": {
                "id": 2683,
                "therapyName": "Tazemetostat",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9115,
                    "pubMedId": 28135235,
                    "title": "An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28135235"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11147,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, diffuse large B-cell lymphoma cells co-expressing EZH2 F120L and EZH2 Y111N were resistant to EI1 in culture, demonstrating no inhibition of cell proliferation (PMID: 28135235).",
            "molecularProfile": {
                "id": 27920,
                "profileName": "EZH2 Y111N EZH2 F120L"
            },
            "therapy": {
                "id": 2927,
                "therapyName": "EI1",
                "synonyms": null
            },
            "indication": {
                "id": 50745,
                "name": "diffuse large B-cell lymphoma",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 9115,
                    "pubMedId": 28135235,
                    "title": "An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28135235"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26050,
            "profileName": "EZH2 Y111N",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 27920,
            "profileName": "EZH2 Y111N EZH2 F120L",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 171519,
            "transcript": "NM_004456",
            "gDna": "chr7:g.148832666A>T",
            "cDna": "c.331T>A",
            "protein": "p.Y111N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171521,
            "transcript": "XM_011515889",
            "gDna": "chr7:g.148829815A>T",
            "cDna": "c.331T>A",
            "protein": "p.Y111N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171518,
            "transcript": "NM_001203247",
            "gDna": "chr7:g.148832666A>T",
            "cDna": "c.331T>A",
            "protein": "p.Y111N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 171520,
            "transcript": "XM_011515884",
            "gDna": "chr7:g.148832666A>T",
            "cDna": "c.331T>A",
            "protein": "p.Y111N",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}